CytomX Therapeutics: Q1 Earnings Insights
CytomX Therapeutics (NASDAQ:CTMX) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:15 PM. Here’s what…
Earnings Scheduled For May 9, 2023
Companies Reporting Before The Bell
• Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million.
AbbVie Walks Away From CytomX Partnership, But Garnering Attention Of Big Pharma Partners
CytomX Therapeutics Inc (NASDAQ:CTMX) will weigh its options for CX-2029, a CD71-directed antibody-drug conjugate, after AbbVie Inc (NYSE:ABBV) decided…
CytomX Therapeutics Earnings Perspective: Return On Capital Employed
CytomX Therapeutics (NASDAQ:CTMX) brought in sales totaling $946 thousand during Q4 according to data provided by Benzinga Pro.…
Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket
Gainers
Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.
Cytomx Therapeutics Inc FY22 Financial Results; FY22 EPS $(1.51); Revenue $53.2M
Full Year 2022 Financial Results
Cash, cash equivalents and investments totaled $194 million as of December 31, 2022, compared to $305 million as of December 31, 2021 and $194 million as of
Cytomx Therapeutics Inc Anticipated IND Filings For Cx-2051 And Cx-801 In Second Half Of 2023
- Internal focus on next generation therapeutic pipeline including ongoing Phase 1 for CX-904 (EGFRxCD3) and anticipated IND filings for CX-2051 (EpCAM-directed ADC) and CX-801 (Interferon alpha-2b) in the second half of 2023 -
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Why Motorsport Games Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Gainers
Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) shares rose 38.5% to $2.05 in pre-market trading after gaining 8% on Friday.